Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4332-01.
Check against the official notice below — it lists the full affected range.
Hospira Inc. is recalling Vancomycin Hydrochloride for Injection, USP, 500 mg, due to temperature abuse during transit. The affected product is one shipment of Lot #34-366-8E02 (expiration date October 1, 2015) containing 200 vials that was sent to The Harvard Drug Group in Livonia, Michigan. The products remained in the distributor's control and were not distributed further to other locations.
The recall notice does not specify a remedy or instructions for affected consumers.
Written by software from the official notice below. Not reviewed by a lawyer.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Reason for recall: Temperature Abuse: Products experienced uncontrolled temperature excursions during transit. Distribution: Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribution was Nationwide for the Vancomycin 1 g product. Quantity: 200 vials Lot/code info: One shipment of Lot #: 34-366-8E02; Exp 1OCT2015 to The Harvard Drug Group, Livonia, MI
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.